needle syringes News
-
Modernizing the Patient Experience
There are self-driving cars, 5G smartphones, and now planes that travel from New York to London in 3.5 hours. The world we live in and the technology we use are rapidly evolving. But, when it comes to drug delivery methods, the 160-year old technology behind the needle and syringe has yet to catch wind of any radical transformation. With cutting-edge technology from MIT, Portal Instruments aims ...
-
Announcement: Numedico and Omikron Group
Numedico Technologies Pty Ltd (Numedico) and Omikron Group Ltd (OGL) are pleased to announce the completion and settlement of the acquisition of the global ClickZip assets and Omikron business. Signed in May 2020, the acquistion brings the assets and international business of the ClickZip® Needle Retractable Safety Syringe into Numedico’s expanding portfolio of safe medical devices and ...
-
Enesi Pharma Achieves Preclinical Proof-of-Concept with ImplaVax-Enabled Pandemic Influenza Vaccine
Innovative needle-free injectable unit solid-dose presentation of recombinant H7N9 pandemic flu vaccine, created using Enesi’s ImplaVax technology, generated immune responses comparable with liquid vaccine and demonstrated excellent thermal stability at temperatures up to 40°C for six months. Enesi Pharma (“Enesi”), an innovative biotechnology company developing ...
-
Doctors, Dentists, Veterinarians and Other Healthcare Professionals and Facilities Prevent Improper Disposal of Over 600 Million Needles and Syringes
Sharps Compliance Corp. (NASDAQ: SMED), a leading full-service provider of cost-effective management solutions for medical waste and unused dispensed medications generated outside the hospital and large healthcare facility setting, is helping healthcare professionals including doctors, dentists, vets, clinics, assisted living and skilled nursing facilities save time, money and the environment ...
-
Vaxxas and University of Sydney complete study assessing needle-free HD-MAP technology for vaccine administration
Australian biotechnology company, Vaxxas Pty Ltd (Vaxxas), in collaboration with the University of Sydney Institute for Infectious Diseases, Faculty of Medicine and Health, has completed a study assessing the usability and acceptability of its novel High-Density Microarray Patch (HD-MAP) to administer vaccines. The HD-MAP is Vaxxas’ proprietary vaccine patch technology, representing a ...
By Vaxxas, Inc.
-
Enesi Pharma ImplaVax Solid Dose Needle-free Vaccination Technology Featured on Leading News Channel in Japan
Enesi Pharma recently hosted a crew from Asahi TV, one of Japan’s leading TV channels, at its Oxford, UK facility to talk about the potential of its ImplaVax® solid dose needle-free vaccination technology. The conversation coincided with the approval of the Pfizer/BioNTech COVID-19 vaccine Comirnaty® in Japan and potential dose-wasting issues linked to the type of syringe used in ...
-
Qprotyn achieves viscosity of 18cP for 250mg/mL of Trastuzumab using its HILOPRO technology.
Upgrading Trastuzumab from IV to Subcutaneous (SubQ) administration may now be possible without expensive, high-volume hyaluronidase injections. Due to patients’ convenience of at-home administration and reduced number of hospital visits as well as the reduction in treatment costs, SubQ administration of biologics is of increasing interest. Trastuzumab targets Human IgG1/TNFα ...
By Qprotyn Inc
-
BARDA-funded Intranasal Antibody Cocktail for COVID-19 Shows Promise in a Preclinical Study
Lumen Bioscience — a clinical stage biopharmaceutical company developing biologic drugs for highly prevalent diseases — announced today preliminary results from a Biomedical Advanced Research and Development Authority (BARDA)-supported effort to develop an intranasal formulation of its drug candidate, LMN-301. This drug, produced in spirulina, contains an antibody cocktail for ...
-
Micron Biomedical Progresses with Clinical Evaluation of its Technology for Measles-Rubella Vaccination
Under $6.745 Million Grant from the Bill & Melinda Gates Foundation ATLANTA, Sept. 1, 2020 /PRNewswire/ — Micron Biomedical, Inc. (Micron) recently received a second tranche of funding ($2.6M) to continue clinical development of its microneedle-based technology for measles and rubella vaccination from the Bill & Melinda Gates Foundation. This work leverages Micron’s ...
-
Enesi Pharma Achieves Key Milestone in Development of Thermostable Solid-dose Live Vaccines against Measles and Rubella
Enesi Pharma (“Enesi”), an innovative biotechnology company developing next-generation vaccination products targeting infectious diseases and emergent threat pathogens enabled by its ImplaVax® technologies, announces it has achieved a key milestone in its project to develop needle-free thermostable unit solid-dose live vaccines with retained activity against Measles and Rubella. ...
-
Gerresheimer and Portal enter strategic partnership to treat chronically ill patients with innovative needle-free drug-delivery solution
Gerresheimer AG is expanding its portfolio of highly-innovative platform technologies for drug delivery. Gerresheimer, a leading provider of healthcare & beauty solutions and drug delivery systems for pharma, biotech and cosmetics, today announced an investment into US-based Portal Instruments, a developer of a next-generation needle-free drug delivery technology. Together, the partners aim ...
-
RepliCel Announces Material Patent Milestones
RepliCel Life Sciences Inc. (OTCPK: REPCF) (TSXV: RP) (FRA:P6P2) (“RepliCel” or the “Company”), a company developing novel, next-generation injection technologies as well as regenerative medicine products in aesthetics and orthopedics, is pleased to announce the filing of a new patent application covering novel aspects of the DermaPrecise™ product portfolio as well ...
-
Flat Medical Announces CE Approval for EpiFaith® Syringe for localization of the Epidural Space
Flat Medical, a startup company based in Taiwan focused on the safety issue of blind puncture of clinical practice. Today, Flat Medical announced it has received CE Mark approval for EpiFaith® syringe, the epidural locating syringe with faith signal. Locating the epidural space is an indispensable part of obstetrical analgesia, surgical anesthesia, postoperative analgesia, and chronic pain ...
By Flat Medical
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you